AstraZeneca Brilinta (Tikagrelor) 90mg In Pakistan \ MyTelestore.com

AstraZeneca Brilinta (Ticagrelor) 90mg is a prescription antiplatelet medicine containing ticagrelor. It works by reducing platelet activation and aggregation, helping reduce the formation of harmful blood clots in patients for whom antiplatelet treatment is medically indicated.

Brilinta 90mg is commonly used as part of treatment following certain acute coronary events, including acute coronary syndrome (ACS), and may be prescribed together with low-dose aspirin when appropriate. Treatment should always be based on a healthcare professional's assessment and prescription.

Key Benefits & Medical Uses

• Antiplatelet Action: Helps prevent platelets from sticking together and forming blood clots.
• Cardiovascular Protection: Used in appropriate patients to reduce the risk of certain cardiovascular thrombotic events.
• Acute Coronary Syndrome: Used in specific patients with ACS as part of an overall treatment plan.
• Post-Heart Attack Treatment: May be prescribed for certain patients with a history of myocardial infarction according to the prescribed regimen.
• Convenient 90mg Strength: Provides a commonly prescribed ticagrelor strength for appropriate treatment regimens.

How Brilinta Works

Ticagrelor is a P2Y12 platelet inhibitor. It reversibly blocks the P2Y12 receptor on platelets, reducing platelet activation and aggregation. This decreases the ability of platelets to contribute to the formation of blood clots.

Product Details

• Brand: Brilinta
• Manufacturer: AstraZeneca
• Active Ingredient: Ticagrelor
• Strength: 90mg
• Dosage Form: Tablet
• Medicine Class: Antiplatelet / P2Y12 inhibitor
• Category: Prescription medicine
• Route: Oral

Important Safety Information

The most important risk associated with ticagrelor is bleeding. Seek urgent medical attention for severe or uncontrolled bleeding, blood in urine or stool, vomiting blood, or other signs of significant bleeding.

Brilinta may also cause shortness of breath (dyspnea) in some patients.

Tell your doctor about any history of bleeding, recent surgery, stomach ulcers, stroke, liver problems, or other medical conditions. Also inform your healthcare professional about all prescription medicines, over-the-counter medicines, supplements, and herbal products you use.

Do not stop taking Brilinta suddenly without speaking with your doctor. Stopping antiplatelet treatment prematurely can increase the risk of cardiovascular events in patients who require ongoing antiplatelet therapy.